Remove 2023 Remove Packaging Remove Vaccines
article thumbnail

Aseptic packaging market to value $35bn by 2033

European Pharmaceutical Review

According to a report by Research Nester, the global aseptic packaging market is projected to reach a revenue of $35 billion by 2033 and is estimated to reach a compound annual growth rate (CAGR) of 10 percent between 2023 and 2033. According to the report, European production has grown by approximately 5.4

Packaging 105
article thumbnail

USP General Chapter —Glass revised

European Pharmaceutical Review

In response to supply chain challenges, including shortages of critical glass vials for products like COVID-19 vaccines and parenteral drugs, the Packaging and Distribution Expert Committee (PD EC) has made a significant revision of United States Pharmacopeia (USP) General Chapter <660>—Glass.

Packaging 105
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Breaking through the forecasting fog – 3 trends that will impact critical medicine supply in 2023

pharmaphorum

It’s wise advice from the “Sage of Omaha”; indeed, one highly respected financial newspaper began its 2023 predictions by conceding that it had been wrong on five major counts for 2022. The same goes for many commodities used in the production process for key medicines, from solvents through to packaging.

Packaging 105
article thumbnail

Top 5 Reasons to Attend the 2023 ISPE Aseptic Conference

ISPE

Top 5 Reasons to Attend the 2023 ISPE Aseptic Conference. Top 5 Reasons to Attend the 2023 ISPE Aseptic Conference. From aseptic manufacturing, process development, primary packaging selection to finished goods – you will be able to gain a lot more technical experiences by speaking to colleagues in the industry. Trudy Patterson.

article thumbnail

2021: the year mRNA therapeutics came of age

pharmaphorum

It started with two Covid-19 vaccines – 2021 is the year interest in mRNA therapeutics boomed, reports Katrina Megget. The Covid-19 pandemic showed what could be done with resources and collaboration to accelerate the development of vaccines. There are multiple other mRNA vaccines that are being developed.

Vaccines 105
article thumbnail

Transdermal and Microneedle Drug Delivery 2023

pharmaphorum

The 2023 Transdermal and Microneedle Drug Delivery Conference will explore real world applications of microneedles in drug delivery and strategies for advanced and user-centric device design. Other key areas will be microneedle vaccines and transdermal patches for management of chronic disease. Primary Packaging Material Designers.

article thumbnail

Preventing fungal contamination in pharmaceuticals

European Pharmaceutical Review

Additionally, this can be caused by “poor handling, repackaging, and nonadherence to good manufacturing practices [GMP] during dispensing and packaging have resulted in the microbiological contamination of non-sterile pharmaceutical products.” Ahmed et al.